Journal article · 2026
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
New England Journal of Medicine, 394(13), 1257–1269 · Published 18 February 2026 · DOI 10.1056/nejmoa2511674
In brief
“Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer” is a 2026 journal article by Christof Vulsteke and 25 co-authors, published in New England Journal of Medicine. OpenAlex counts 161 citations as of 16 November 2026, which puts it in the top 1% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 161
- Most cited in
- 2026 (161)
- Field-weighted impact
- 692.79
- References
- 23
- Authors
- 26
Abstract
BACKGROUND: Patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy proceed directly to radical cystectomy with pelvic lymph-node dissection. Perioperative therapy may improve outcomes in this population. METHODS: In this phase 3, open-label trial, participants with muscle-invasive bladder cancer who were ineligible for or declined cisplatin-based chemotherapy were randomly assigned to perioperative (neoadjuvant… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Vulsteke, C., Adra, N., Danchaivijitr, P., Сабадаш, М. Є., Rodríguez‐Vida, A., Zhang, Z., Atduev, V., Goger, Y., Rausch, S., Kang, S.-H., Loriot, Y., Bedke, J., Galsky, M. D., O’Donnell, P. H., Amsberg, G. V., Alimohamed, N. S., Sulimka, G., Gupta, S., Paramonov, V., . . . Ullén, A. (2026). Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. New England Journal of Medicine, 394(13), 1257–1269. https://doi.org/10.1056/nejmoa2511674
MLA 9
Vulsteke, Christof, et al. “Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.” New England Journal of Medicine, vol. 394, no. 13, 2026, pp. 1257–1269. https://doi.org/10.1056/nejmoa2511674.
Chicago
Vulsteke, Christof, Nabil Adra, Pongwut Danchaivijitr, М. Є. Сабадаш, Alejo Rodríguez‐Vida, Zhentao Zhang, Vagif Atduev, et al. 2026. “Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.” New England Journal of Medicine 394 (13): 1257–1269. https://doi.org/10.1056/nejmoa2511674.
Harvard
Vulsteke, C. et al. (2026) ‘Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer’, New England Journal of Medicine, 394(13), pp. 1257–1269. doi:10.1056/nejmoa2511674.
IEEE
C. Vulsteke et al., “Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer,” New England Journal of Medicine, vol. 394, no. 13, pp. 1257–1269, 2026, doi: 10.1056/nejmoa2511674.
BibTeX
@article{vulsteke2026perioperative,
title = {{Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer}},
author = {Vulsteke, Christof and Adra, Nabil and Danchaivijitr, Pongwut and Сабадаш, М. Є. and Rodríguez‐Vida, Alejo and Zhang, Zhentao and Atduev, Vagif and Goger, Y.E. and Rausch, Steffen and Kang, Seok-Ho and Loriot, Yohann and Bedke, Jens and Galsky, Matthew D. and O’Donnell, Peter H. and Amsberg, Gunhild v. and Alimohamed, Nimira S. and Sulimka, Grzegorz and Gupta, Shilpa and Paramonov, V.V. and Nakane, Keita and Mihm, Michael and Meng, Changting and Huang, Caizhi David and Ramamurthy, Chethan and Moreno, Blanca Homet and Ullén, Anders},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {13},
pages = {1257--1269},
doi = {10.1056/nejmoa2511674},
url = {https://doi.org/10.1056/nejmoa2511674}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- muscle-invasive bladder cancer
- enfortumab vedotin
- pembrolizumab
- perioperative therapy
- neoadjuvant therapy
- adjuvant therapy
- antibody-drug conjugates
- nectin-4
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Vulsteke, C., Adra, N., Danchaivijitr, P., Сабадаш, М. Є., Rodríguez‐Vida, A., Zhang, Z., Atduev, V., Goger, Y., Rausch, S., Kang, S.-H., Loriot, Y., Bedke, J., Galsky, M. D., O’Donnell, P. H., Amsberg, G. V., Alimohamed, N. S., Sulimka, G., Gupta, S., Paramonov, V., . . . Ullén, A. (2026). Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. New England Journal of Medicine, 394(13), 1257–1269. https://doi.org/10.1056/nejmoa2511674
How many times has this paper been cited?
161 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, М. Є. Сабадаш, Alejo Rodríguez‐Vida, Zhentao Zhang, Vagif Atduev, Y.E. Goger, Steffen Rausch, Seok-Ho Kang, Yohann Loriot, Jens Bedke and 14 more.
What is the DOI of this paper?
10.1056/nejmoa2511674, permanently at https://doi.org/10.1056/nejmoa2511674. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.